Trinity Biotech (TRIB) Net Margin (2009 - 2024)
Trinity Biotech recorded quarterly Net Margin of 99.62% in Q4 2024, down 214.87% quarter-over-quarter from 31.64% in Q3 2024, and down 5948.0% year-over-year from 1.7% in Q1 2024.
Trinity Biotech's Net Margin history runs 16 years deep, the most recent figure standing at 99.62% for Q4 2024.
- In Q4 2024, Net Margin fell 5948.0% year-over-year to 99.62%; the TTM figure through Dec 2024 stood at 49.82% (up 1506.0% YoY), while the FY2025 annual figure was 85.36%, down 3372.0% from the prior year.
- Net Margin came in at 99.62% for Q4 2024 at Trinity Biotech, down from 31.64% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 33.38% in Q3 2020 to a low of 135.85% in Q2 2023.
- A 5-year average of 28.67% and a median of 26.64% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin slumped 13578 bps in 2023 and jumped 9235 bps in 2024, its largest moves.
- Trinity Biotech's Net Margin stood at 31.62% in 2020, then plunged by 155 bps to 17.23% in 2021, then sank by 285 bps to 66.4% in 2022, then jumped by 40 bps to 40.14% in 2023, then plunged by 148 bps to 99.62% in 2024.
- According to Business Quant data, Net Margin over the past three periods registered 99.62%, 31.64%, and 43.5% for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -99.62% |
| Sep 30, 2024 | -31.64% |
| Jun 30, 2024 | -43.50% |
| Mar 31, 2024 | -21.65% |
| Dec 31, 2023 | -40.14% |
| Sep 30, 2023 | -42.76% |
| Jun 30, 2023 | -135.85% |
| Mar 31, 2023 | -42.67% |
| Dec 31, 2022 | -66.40% |
| Sep 30, 2022 | -63.58% |
| Jun 30, 2022 | -0.06% |
| Mar 31, 2022 | -84.34% |
| Dec 31, 2021 | -17.23% |
| Sep 30, 2021 | 8.42% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 17.16% |
| Dec 31, 2020 | 31.62% |
| Sep 30, 2020 | 33.38% |
| Jun 30, 2020 | 10.95% |
| Mar 31, 2020 | 14.42% |
| Dec 31, 2019 | 7.95% |
| Sep 30, 2019 | 10.87% |
| Jun 30, 2019 | 36.00% |
| Mar 31, 2019 | 12.11% |
| Dec 31, 2018 | 13.05% |
| Sep 30, 2018 | 10.01% |
| Jun 30, 2018 | 12.17% |
| Mar 31, 2018 | 13.01% |
| Dec 31, 2017 | 3.90% |
| Sep 30, 2017 | 10.75% |
| Jun 30, 2017 | 12.48% |
| Mar 31, 2017 | 10.95% |
| Dec 31, 2016 | -182.69% |
| Sep 30, 2016 | -0.85% |
| Jun 30, 2016 | 9.00% |
| Mar 31, 2016 | -4.18% |
| Dec 31, 2015 | 13.12% |
| Sep 30, 2015 | 50.23% |
| Jun 30, 2015 | 12.90% |
| Mar 31, 2015 | 18.29% |
| Dec 31, 2014 | 16.86% |
| Sep 30, 2014 | 18.09% |
| Jun 30, 2014 | 18.72% |
| Mar 31, 2014 | 18.55% |
| Dec 31, 2013 | 20.81% |
| Sep 30, 2013 | 22.80% |
| Jun 30, 2013 | 20.57% |
| Mar 31, 2013 | 22.22% |
| Dec 31, 2012 | 25.55% |
| Sep 30, 2012 | 25.80% |
| Jun 30, 2012 | 26.09% |
| Mar 31, 2012 | 26.19% |
| Dec 31, 2011 | 26.77% |
| Sep 30, 2011 | 27.02% |
| Jun 30, 2011 | 26.57% |
| Mar 31, 2011 | 26.39% |
| Sep 30, 2010 | -3.13% |
| Jun 30, 2010 | 208.00% |
| Mar 31, 2010 | 12.87% |
| Dec 31, 2009 | 10.58% |
| Sep 30, 2009 | 12.07% |
| Jun 30, 2009 | 12.32% |
| Mar 31, 2009 | 9.66% |